ArticlePeerJ2020

Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways.

Panpan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.